3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Cystitis, Interstitial
1
Interventions
Magnetic Resonance Spectroscopy
107
Specimen Handling
89
pembrolizumab
82
enzalutamide
65
Nivolumab
64
Gemcitabine
59
Docetaxel
51
Abiraterone Acetate
44
apalutamide
43
Radiosurgery
43
Androgen Antagonists
43
Prednisone
42
darolutamide
40
Cisplatin
38
Biopsy
38
cabozantinib
34
Radiotherapy
34
Carboplatin
30
abiraterone
29
Pluvicto
29
Ipilimumab
29
durvalumab
25
enfortumab vedotin
24
Leuprolide
24
X-Rays
23
Radiation
23
atezolizumab
22
olaparib
20
Standard of Care
20
avelumab
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
chondroitin sulfate, sodium hyaluronate drug combination
×
Genitourinary
×
90 days
×
Clear all
NCT07495072
2026-03-27
PRO-GAG
BLAD-HYA Group
Phase NA
Recruiting
56 enrolled